Suppr超能文献

TG-43U1 parameterization of elongated RadioCoil 103Pd brachytherapy sources.

作者信息

Dini Sharifeh A, Awan Shahid B, Dou Kai, Meigooni Ali S

机构信息

Department of Radiation Medicine, University of Kentucky Chandler Medical Center, Lexington, Kentucky, U.S.A.

出版信息

J Appl Clin Med Phys. 2007 Jul 17;8(3):60-75. doi: 10.1120/jacmp.v8i3.2435.

Abstract

Recently, to eliminate problems associated with seed type sources, RadioMed Corporation (Tyngsboro, MA) introduced RadioCoil 103Pd sources for interstitial prostate implants. The RadioCoil sources are available in integral lengths ranging from 1.0 cm to 6.0 cm. In this project, dosimetric characteristics of these sources were determined following the TG-43U1 recommendations, with consideration of our recent publication on the evaluation of two-dimensional anisotropy function for elongated brachytherapy sources. Dosimetric parameters of these sources were determined experimentally in Solid Water (Gammex RMI, Middleton, WI) and theoretically using Monte Carlo simulation in Solid Water and liquid water. Per the TG-43U1 protocol, the consensus of these results would be used for their clinical applications.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8d0/5722604/8ca6a1133a15/ACM2-8-060-g001.jpg

相似文献

1
TG-43U1 parameterization of elongated RadioCoil 103Pd brachytherapy sources.
J Appl Clin Med Phys. 2007 Jul 17;8(3):60-75. doi: 10.1120/jacmp.v8i3.2435.
4
Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.
J Appl Clin Med Phys. 2008 Apr 16;9(2):123-142. doi: 10.1120/jacmp.v9i2.2760.
7
Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
J Appl Clin Med Phys. 2007 Mar 20;8(2):18-25. doi: 10.1120/jacmp.v8i2.2393.
8
Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Appl Radiat Isot. 2006 Aug;64(8):881-7. doi: 10.1016/j.apradiso.2006.03.015. Epub 2006 May 18.
9
Brachytherapy dosimetry parameters calculated for a new 103Pd source.
Med Phys. 2004 Sep;31(9):2466-70. doi: 10.1118/1.1781552.

引用本文的文献

1
Evaluation of hypothetical (153)Gd source for use in brachytherapy.
Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):17-24. doi: 10.1016/j.rpor.2015.05.005. Epub 2015 Jun 27.
2
Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.
J Appl Clin Med Phys. 2011 Nov 15;12(4):3581. doi: 10.1120/jacmp.v12i4.3581.
3
Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.
J Appl Clin Med Phys. 2008 Apr 16;9(2):123-142. doi: 10.1120/jacmp.v9i2.2760.

本文引用的文献

1
New National Air-Kerma-Strength Standards for (125)I and (103)Pd Brachytherapy Seeds.
J Res Natl Inst Stand Technol. 2003 Oct 1;108(5):337-58. doi: 10.6028/jres.108.030. Print 2003 Sep-Oct.
5
Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.
J Appl Clin Med Phys. 2005 Summer;6(3):23-36. doi: 10.1120/jacmp.v6i3.2097. Epub 2005 Aug 12.
9
The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancer.
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):397-9. doi: 10.1016/j.ijrobp.2003.10.034.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验